Cough due to upper respiratory tract infection(common cold). Acute nasopharyngitis [common cold]
Conditions
Interventions
Intervention 1: Intervention group: The oral syrup from sweet almond (equivalent to the dose of Diphenhydramine syrup received in the control group: 1 mg/ kg ) will be prescribed in 1 Dose half an ho
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: The patients's age is two to twelve years old Cough due to upper respiratory tract infection (common cold) for less than 7 days Concomitant symptoms (mild fever: less than 39 ° C, sore throat, cramps, rhinorrhea, mild headache, feeling tired, sneezing Do not use any anti-cough product 18 hours before the intervention Lack of underlying disease (asthma, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease) Conscious written consciously from parents to enter the study Possibility of patient Follow up
Exclusion criteria
Exclusion criteria: Children with signs and symptoms of asthma, pneumonia, allergic rhinitis, sinusitis, laryngo tracheobronchitis, congenital heart disease, chronic lung disease, diabetes, kidney disease The onset of symptoms of otitis, sinusitis, onset of symptoms of of the lower respiratory tract infection , the addition of a bacterial infection to the viral infection (edema, respiratory problem, severe sore throat with painful ingestion, nausea, vomiting, fever above 39 °, septic nasal discharge, Facial and peri orbital pain) during the intervention Lack of allergy (presence of symptoms such as i itchy eye & nose, a history of prolonged cold periods,history of repeating similar symptoms, positive family history of allergy, history of drug and food allergy), The presence of sign and symptoms of a Reactive Airway Disease including: tachypnea and tachycardia, short breath, chest tightness ) Getting any anti cough drug before intervention Not using or using irregularly recommended medications Add other cough drugs to treatment during the intervention allergic reaction to drug combinations during the study disrelish to cooperate until the end of the study Inaccessibility of the patient during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough frequency. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Cough severity. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Nightly sleep quality of the child. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist.;Nightly sleep quality of the parent. Timepoint: At the beginning of the study, the first and second day of intervention. Method of measurement: Likert scale Checklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time Control Signs. Timepoint: Any time during the study. Method of measurement: Report by the child's parents. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Karimi
Iran University of Medical Sciences
Outcome results
None listed